Care pathways, referrals and service utilisation
Study aggregate patterns or operational questions within an agreed scope and time period.
OPES Health Systems invites hospitals, clinics, pharmacies, pharmaceutical companies, laboratories and other health institutions to discuss licensing de-identified data to OPES for research and health-system improvement projects.
Tell us about your institution and the research question you have in mind. This initial enquiry transfers no data and does not constitute a licence agreement.
We want to hear from institutions that generate or hold health data and are considering authorising its use for a defined, governed purpose that can contribute to care or public health.
The examples below are topics for discussion, not a claim that these datasets are available. Purpose, source, fields, time period and outputs are agreed with each institution.
Study aggregate patterns or operational questions within an agreed scope and time period.
Study aggregate patterns or operational questions within an agreed scope and time period.
Study aggregate patterns or operational questions within an agreed scope and time period.
Study aggregate patterns or operational questions within an agreed scope and time period.
Study aggregate patterns or operational questions within an agreed scope and time period.
Study aggregate patterns or operational questions within an agreed scope and time period.
A licence does not replace a lawful basis, institutional approvals, confidentiality obligations or ethics review that may apply. Removing direct identifiers alone does not eliminate all risk.
Confirm the institution’s rights, lawful basis, approvals and, where required, ethics review before any use.
Define and assess the de-identification methods and residual re-identification risk for the data and its context.
Document a specific purpose, authorised users, retention period, restrictions and deletion requirements.
Set access controls, security measures, incident duties and a contractual prohibition on re-identification.
Describe the institution and high-level need without sending any data.
Review rights, purpose, approvals, risks and operational capability.
Agree fields, access, responsibilities, duration, any fees and restrictions.
Start only after required approvals, contracts and security controls are in place.
Direct identifiers are removed or transformed and residual risk is assessed. The label alone does not establish that a dataset is anonymous or risk-free.
Do not send patient records or identifiers through the website form or by email. Any source or transfer requires prior review of authority, purpose, safeguards and contractual terms.
Hospitals, clinics, pharmacies, pharmaceutical companies, laboratories, public health programmes, universities and research institutions can submit a high-level proposal.
No. This page invites proposals for discussion. Each project, dataset, approval, availability, licence and safeguard must be reviewed and agreed separately.
Tell us about your organisation and proposal at a high level. Do not send records, patient identifiers, data samples or sensitive information through the form or by email.